RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Legend Biotech Stock

Legend Biotech Equity 2025

Legend Biotech Equity

1.04 B USD

Ticker

LEGN

ISIN

US52490G1022

WKN

A2P5AH

In 2025, Legend Biotech's equity was 1.04 B USD, a -16.85% increase from the 1.25 B USD equity in the previous year.

Legend Biotech Aktienanalyse

What does Legend Biotech do?

Legend Biotech Corp is a leading biopharmaceutical company specializing in the discovery and development of innovative cell therapies for the treatment of serious diseases such as cancer. The company was founded in 2015 as a subsidiary of Genscript Biotech Corp and is headquartered in Somerset, New Jersey, USA. Additionally, the company also operates locations in China and Europe. Legend Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Legend Biotech's Equity

Legend Biotech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Legend Biotech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Legend Biotech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Legend Biotech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Legend Biotech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Legend Biotech stock

What is the equity of Legend Biotech this year?

Legend Biotech has equity of 1.04 B USD this year.

What was the equity of Legend Biotech compared to the previous year?

The equity of Legend Biotech has increased/decreased by -16.85% decreased compared to the previous year.

What impact does a high equity have on investors of Legend Biotech?

A high equity is advantageous for investors of Legend Biotech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Legend Biotech?

A low equity can be a risk for investors of Legend Biotech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Legend Biotech affect the company?

An increase in equity of Legend Biotech can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Legend Biotech affect the company?

A reduction in equity of Legend Biotech can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Legend Biotech?

Some factors that can affect the equity of Legend Biotech include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Legend Biotech so important for investors?

The equity of Legend Biotech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Legend Biotech take to change the equity?

To change equity, Legend Biotech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Legend Biotech pay?

Over the past 12 months, Legend Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Legend Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Legend Biotech?

The current dividend yield of Legend Biotech is .

When does Legend Biotech pay dividends?

Legend Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Legend Biotech?

Legend Biotech paid dividends every year for the past 0 years.

What is the dividend of Legend Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Legend Biotech located?

Legend Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Legend Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Legend Biotech from 8/9/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/9/2025.

When did Legend Biotech pay the last dividend?

The last dividend was paid out on 8/9/2025.

What was the dividend of Legend Biotech in the year 2024?

In the year 2024, Legend Biotech distributed 0 USD as dividends.

In which currency does Legend Biotech pay out the dividend?

The dividends of Legend Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Legend Biotech

Our stock analysis for Legend Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Legend Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.